Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s40291-013-0023-x.

Title:
Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests | Molecular Diagnosis & Therapy
Description:
Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,151,168 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {๐Ÿ”}

cancer, google, scholar, bladder, article, pubmed, cas, urine, detection, bca, patients, test, biomarkers, urol, urinary, cytology, tumor, tests, analysis, study, markers, cells, molecular, disease, studies, assay, clinical, carcinoma, urothelial, diagnostic, samples, diagnosis, sensitivity, assays, protein, res, specificity, biomarker, clin, cell, nmp, potential, serum, tumors, profiling, genes, bta, hematuria, surveillance, voided,

Topics {โœ’๏ธ}

local-learning-based feature selection urokinase plasminogen activator quantitative methylation-specific rt-pcr high-pressure liquid chromatography icud-eau international consultation magnetic bead-based separation article download pdf urine-based tumour markers key post-transcriptional regulators genome-wide mrna profiles mrna-based diagnostic urinalyses gelatin-bound urinary proteins extensive long-term surveillance muscle-invasive papillary tumors ha-haase urine tests high-throughput proteomic technologies potentially causing false-positive muscle-invasive bladder carcinoma quantitative rt-pcr test multiplex urine-based assay nuclear matrix protein nuclear matrix protein-22 nuclear protein matrix muscle-invasive bladder cancer muscle-invasive urothelial carcinoma high-dimensional data analysis blood-based biomarker tests invasive urine-based assay circulating tumour cells von der maase blood-based marker tests rosserย &ย virginia urquidi urine-spiking models confirm nmr-based metabolomic analysis circulating uroplakin-positive cells ms-based urinary analysis privacy choices/manage cookies identify serum-based biomarkers high-grade urothelial carcinoma preoperative plasma levels van rhijn bw separate cross-validation study transitional cell carcinoma false-positive bta tests urinary microrna reveals human complement factor van der kwast ubiquitous nuclear protein urothelial cell carcinomas urological clinical material

Questions {โ“}

  • Are nomograms needed in the management of bladder cancer?
  • Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)โ€”useful diagnostic tools in the diagnosis of urinary bladder cancer?

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
         description:Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.
         datePublished:2013-03-12T00:00:00Z
         dateModified:2013-03-12T00:00:00Z
         pageStart:71
         pageEnd:84
         sameAs:https://doi.org/10.1007/s40291-013-0023-x
         keywords:
            Transitional Cell Carcinoma
            Psoriasin
            Nuclear Matrix Protein
            CellSearch System
            Bladder Disease
            Molecular Medicine
            Human Genetics
            Cancer Research
            Laboratory Medicine
            Pharmacotherapy
         image:
         isPartOf:
            name:Molecular Diagnosis & Therapy
            issn:
               1179-2000
               1177-1062
            volumeNumber:17
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing AG
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Steve Goodison
               affiliation:
                     name:MD Anderson Cancer Center Orlando
                     address:
                        name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Charles J. Rosser
               affiliation:
                     name:MD Anderson Cancer Center Orlando
                     address:
                        name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Virginia Urquidi
               affiliation:
                     name:MD Anderson Cancer Center Orlando
                     address:
                        name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
      description:Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.
      datePublished:2013-03-12T00:00:00Z
      dateModified:2013-03-12T00:00:00Z
      pageStart:71
      pageEnd:84
      sameAs:https://doi.org/10.1007/s40291-013-0023-x
      keywords:
         Transitional Cell Carcinoma
         Psoriasin
         Nuclear Matrix Protein
         CellSearch System
         Bladder Disease
         Molecular Medicine
         Human Genetics
         Cancer Research
         Laboratory Medicine
         Pharmacotherapy
      image:
      isPartOf:
         name:Molecular Diagnosis & Therapy
         issn:
            1179-2000
            1177-1062
         volumeNumber:17
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing AG
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Steve Goodison
            affiliation:
                  name:MD Anderson Cancer Center Orlando
                  address:
                     name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Charles J. Rosser
            affiliation:
                  name:MD Anderson Cancer Center Orlando
                  address:
                     name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Virginia Urquidi
            affiliation:
                  name:MD Anderson Cancer Center Orlando
                  address:
                     name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Diagnosis & Therapy
      issn:
         1179-2000
         1177-1062
      volumeNumber:17
Organization:
      name:Springer International Publishing AG
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:MD Anderson Cancer Center Orlando
      address:
         name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
         type:PostalAddress
      name:MD Anderson Cancer Center Orlando
      address:
         name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
         type:PostalAddress
      name:MD Anderson Cancer Center Orlando
      address:
         name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Steve Goodison
      affiliation:
            name:MD Anderson Cancer Center Orlando
            address:
               name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Charles J. Rosser
      affiliation:
            name:MD Anderson Cancer Center Orlando
            address:
               name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
               type:PostalAddress
            type:Organization
      name:Virginia Urquidi
      affiliation:
            name:MD Anderson Cancer Center Orlando
            address:
               name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
      name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA
      name:Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, USA

External Links {๐Ÿ”—}(448)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.76s.